- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Most Popular Stocks
Global Pharmaceuticals & Biotech Most Popular Stocks
Results
3042
Most Popular Stocks on the market
3042 companies
Hanall Biopharma
Market Cap: ₩1.6t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩30,700.00
7D
-6.3%
1Y
-18.1%
Kuros Biosciences
Market Cap: CHF 877.3m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 22.72
7D
-2.5%
1Y
22.7%
Enliven Therapeutics
Market Cap: US$1.1b
A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.
ELVN
US$20.01
7D
5.5%
1Y
-17.1%
Aether Industries
Market Cap: ₹97.4b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹734.70
7D
-0.2%
1Y
-20.4%
SSY Group
Market Cap: HK$8.5b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.90
7D
-2.0%
1Y
-28.7%
Collegium Pharmaceutical
Market Cap: US$1.1b
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$34.41
7D
-3.7%
1Y
-10.1%
Beijing Strong BiotechnologiesInc
Market Cap: CN¥7.8b
Provides in-vitro diagnostics products and services in the People’s Republic of China and internationally.
300406
CN¥13.38
7D
-0.9%
1Y
0.6%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥7.8b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥14.30
7D
0.8%
1Y
4.4%
Daewoong Pharmaceutical
Market Cap: ₩1.5t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩132,900.00
7D
-6.1%
1Y
-3.0%
Vetoquinol
Market Cap: €911.8m
A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.
VETO
€77.30
7D
-1.4%
1Y
-8.4%
GC Biopharma
Market Cap: ₩1.5t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩131,700.00
7D
-5.3%
1Y
-12.9%
Northeast Pharmaceutical Group
Market Cap: CN¥7.6b
Engages in chemical pharmaceuticals preparations, pharmaceutical business, pharmaceutical engineering, biomedicine, and other businesses in China.
000597
CN¥5.32
7D
-3.3%
1Y
16.4%
Wave Life Sciences
Market Cap: US$1.1b
A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.
WVE
US$6.80
7D
-1.3%
1Y
-18.0%
Nektar Therapeutics
Market Cap: US$1.1b
A biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally.
NKTR
US$58.50
7D
6.1%
1Y
233.3%
GemPharmatech
Market Cap: CN¥7.5b
A contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide.
688046
CN¥18.42
7D
-0.8%
1Y
44.9%
Shanghai OPM Biosciences
Market Cap: CN¥7.5b
Provides cell culture media and CDMO services in China and internationally.
688293
CN¥66.17
7D
23.9%
1Y
122.8%
Oneness Biotech
Market Cap: NT$32.1b
Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products primarily in Taiwan.
4743
NT$67.20
7D
-0.7%
1Y
-52.5%
Kexing Biopharm
Market Cap: CN¥7.5b
Engages in the research and development, production, and sale of recombinant protein drugs and microbial preparations in China and internationally.
688136
CN¥37.76
7D
-9.8%
1Y
140.1%
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
Market Cap: HK$8.1b
Engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China.
1349
HK$3.47
7D
-7.7%
1Y
60.6%
Zhejiang AngLiKang PharmaceuticalLTD
Market Cap: CN¥7.5b
A pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases.
002940
CN¥37.86
7D
-3.8%
1Y
167.8%
Wedge IndustrialLtd
Market Cap: CN¥7.4b
Engages in the research and development, production, and sale of micro-ecological live bacteria products, superalloys, and related products in China.
000534
CN¥15.42
7D
-0.8%
1Y
48.6%
Hunan Warrant PharmaceuticalLtd
Market Cap: CN¥7.4b
Manufactures and sells pharmaceutical products.
688799
CN¥56.66
7D
-3.8%
1Y
81.1%
Suzhou Sepax Technologies
Market Cap: CN¥7.4b
Researches, develops, produces, and sells liquid chromatography materials for the separation and purification of biomacromolecules and other drugs worldwide.
688758
CN¥17.81
7D
-2.8%
1Y
n/a
Precigen
Market Cap: US$1.0b
A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.
PGEN
US$3.51
7D
-6.4%
1Y
270.8%
Guizhou Bailing Group Pharmaceutical
Market Cap: CN¥7.4b
Guizhou Bailing Group Pharmaceutical Co., Ltd.
002424
CN¥5.42
7D
-4.1%
1Y
51.0%
Praxis Precision Medicines
Market Cap: US$1.0b
A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.
PRAX
US$52.44
7D
24.2%
1Y
-9.3%
Shandong Wit Dyne HealthLtd
Market Cap: CN¥7.4b
Engages in the pharmaceutical business in China.
000915
CN¥31.55
7D
-2.0%
1Y
6.8%
MiMedx Group
Market Cap: US$1.0b
Develops and distributes placental tissue allografts for various sectors of healthcare.
MDXG
US$6.94
7D
-1.1%
1Y
19.0%
Nuvation Bio
Market Cap: US$1.0b
A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.
NUVB
US$3.20
7D
-0.6%
1Y
33.9%
Trevi Therapeutics
Market Cap: US$1.0b
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough.
TRVI
US$8.77
7D
7.6%
1Y
163.4%
BridgeBio Oncology Therapeutics
Market Cap: US$1.0b
A clinical-stage biotechnology company, engages in the development of small-molecule therapeutics targeting renin-angiotensin system and phosphoinositide 3-kinase malignancies.
BBOT
US$11.70
7D
2.5%
1Y
12.0%
Beijing Sun-Novo Pharmaceutical Research
Market Cap: CN¥7.3b
A contract research company, engages in the research and development of drugs in China.
688621
CN¥66.66
7D
-13.4%
1Y
83.7%
Beijing SL Pharmaceutical
Market Cap: CN¥7.3b
A biopharmaceutical company, research, develops, produces, and markets genetic engineering and related drugs in the People’s Republic of China and internationally.
002038
CN¥7.09
7D
-2.5%
1Y
-1.7%
Xiangxue PharmaceuticalLtd
Market Cap: CN¥7.2b
Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China.
300147
CN¥10.93
7D
-2.1%
1Y
53.5%
Tchaikapharma High Quality Medicines AD
Market Cap: лв1.7b
Develops, manufactures, and sells medicines in Bulgaria.
THQM
лв17.70
7D
3.5%
1Y
6.3%
ORIC Pharmaceuticals
Market Cap: US$1.0b
A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States.
ORIC
US$11.12
7D
5.3%
1Y
4.4%